We are an innovative femtech company on a mission to revolutionise the intimate self-care market
Peptonic Medical is dedicated to researching and developing ground breaking products in women’s health improving access to these products on a global scale.
Today our group is home to a holistic range of products that are trusted by experts and loved by customers. Peptonic Medical’s own brand Vagivital provides a strong foundation for the business, but we also work with partners through licensing and white label models internationally.
Our head office is located in Stockholm Sweden, and we also have sales offices in the US, along with a research and development facility in Israel.
Our flagship brand for the medical consumer is VagiVital.
VagiVital’s vision is to enable all women to enjoy and have an inspiring life despite vaginal issues, such as vaginal atrophy. Our goal is to solve any vaginal problem women may have with clinically proven self-care.
Global portfolio of intellectual property with focus on research and innovation. Peptonic is working continuously with innovations protecting developed assets with patents.
Global portfolio of intellectual property with focus on research and innovation. Peptonic is working continuously with innovations protecting developed assets with patents.
For medical conditions in intimate health, there are prescribing products and self-care products. Peptonic's goal is to position the Company between these, with clinically proven intimate self-care and be a leading player with a clear position and profiling. The company's ambition is to achieve this by developing and acquiring an innovative product portfolio that enables the female consumer to manage their intimate health from diagnosis to treatment and to prevent diseases.
Peptonic Medical (publ) (“Peptonic”) is expanding its portfolio of clinically proven intimate self-care products with the launch of VagiVital Active Glide, a water-based lubricant specifically
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN,
Peptonic Medical AB (publ) (“Peptonic”) has received notification that the Australian patent office has granted the FOAM II patent. This patent provides broad protection for
We are constantly looking for new partners, distributors and retailers to grow with us as we're expanding globally. Learn more how to work with us and contact us today to learn more!
Peptonic Medical has been trading on Spotlight in Stockholm since 2014. We are also looking for new investors to fuel our rapid expansion globally.
Every day we work towards making intimate health more accessible. We are constantly on a lookout for new talent to join our team.
